Human Immunodeficiency Virus (HIV) Type-1 GP120-Specific Cell-Mediated Cytotoxicity (CMC) and Natural Killer (NK) Activity in HIV-Infected (HIV + ) Subjects: Enhancement with Interleukin-2(IL-2), IL-12, and IL-15

By Lin S.J.   Roberts R.L.   Ank B.J.   Nguyen Q.H.   Thomas E.K.   Stiehm E.R.  

Clinical Immunology, Vol. 82, Iss. 2, 1997-02 ,pp. : 163-173

Academic Press

Access to resources Recommend Favorite

Donor antigen-independent effector mechanisms of graft rejection: a novel cell surface target of IL-2-activated natural killer cells

By Norin A.J.   Brewer R.J.   Lui Q.   Del Rio M.J.   Burack J.   Kamholz S.L.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 787-788

Elsevier

Access to resources Recommend Favorite

Natural killer cell immune responses

By Yokoyama Wayne  

Immunologic Research, Vol. 32, Iss. 1-3, 2005-06 ,pp. : 317-325

Humana Press, Inc

Access to resources Recommend Favorite

Suppressed Cell-Mediated Immunity and Monocyte and Natural Killer Cell Activity Following Allogeneic Immunization of Women with Spontaneous Recurrent Abortion

By Gafter Uzi   Sredni Benjamin   Segal Jacob   Kalechman Yona  

Journal of Clinical Immunology, Vol. 17, Iss. 5, 1997-09 ,pp. : 408-419

Springer Publishing Company

Access to resources Recommend Favorite

Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration

By Nussenblatt R.B.   Thompson D.J.S.   Li Z.   Peterson J.S.   Robinson R.R.   Shames R.S.   Nagarajan S.   Tang M.T.   Mailman M.   Velez G.   Roy C.   Levy-Clarke G.A.   Suhler E.B.   Djalilian A.   Sen H.N.   Al-Khatib S.   Ursea R.   Srivastava S.   Bamji A.   Mellow S.   Sran P.   Waldmann T.A.   Buggage R.R.  

Journal of Autoimmunity, Vol. 21, Iss. 3, 2003-11 ,pp. : 283-293

Elsevier

Access to resources Recommend Favorite